Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $23.4 Million - $28.3 Million
-5,078,991 Closed
0 $0
Q3 2019

Nov 12, 2020

BUY
$4.99 - $6.16 $1.48 Million - $1.82 Million
296,262 Added 6.19%
5,078,991 $26.2 Million
Q2 2019

May 15, 2020

BUY
$5.92 - $7.41 $28.3 Million - $35.4 Million
4,782,729 New
4,782,729 $0
Q2 2019

Aug 14, 2019

SELL
$5.92 - $7.41 $35.9 Million - $44.9 Million
-6,064,035 Closed
0 $0
Q1 2019

May 15, 2020

BUY
$6.8 - $7.4 $41.2 Million - $44.9 Million
6,064,035 New
6,064,035 $0
Q1 2019

May 13, 2019

SELL
$6.8 - $7.4 $20.4 Million - $22.2 Million
-2,996,814 Closed
0 $0
Q4 2018

Aug 14, 2019

BUY
$3.99 - $7.82 $12 Million - $23.4 Million
2,996,814 New
2,996,814 $22.2 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $418M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.